Share
1,857 Posts.
lightbulb Created with Sketch. 43
clock Created with Sketch. 08/02/19
16:59
Share
Originally posted by RBx:
↑
The ASX places restrictions on the content of company announcements, but that does not stop readers using their brains. Let’s look at the latest announcement by Noxopharm.3/4 patients in the 800 mg cohort and 2/4 patients in the 1200 mg cohort had a pain response of > 30% (52-92%). ” In other words, 5 of 8 patients had pain reduction of 52% to 92%.
Expand
The announcement did seem circumspect, but that's ok for phase I interim, we can't get too wound up yet, despite the inclination of HC folk to do so.
(20min delay)
